ApextradezCOM commented on a stock · Apr 16 16:56

Final Stretch -into 4/26 AH Approval

👉🏻Libervant for pediatric - global sales $2-300+ million per year. HUGE 💵 ** Libervant for adults - Globally is at least double that of pediatrics 500 Mil+ 👉🏻 Anaphylm - global sales $1 billion per year if not more FINALLY 👉🏻 AQST 108 (epinephrine cream) for dermatology- Multi hundred millions. ** REACAP Revenue 📈🚀🥇💯 (buyout) hummm 🤔⏰ Small market cap of $328 million is very undervalued. If you added the potential for Libervant for adults and pediatric together just by themselves this is HUGE - don’t Fool yourself and Miss this boat!!!

there is a plethera of addironal reasons to buy and long term HOLD AQST - Alpha is giving you a chance to WIN BIG ‼️⭐️🫵🏻💯💵👈🏻

$Jaguar Health(JAGX.US)$ $Viking Therapeutics(VKTX.US)$ $X4 Pharmaceuticals(XFOR.US)$ $Day One Biopharmaceuticals(DAWN.US)$ $Tesla(TSLA.US)$

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

63K Views

Comment

ApextradezCOM

Hello Professional Citadel Trader Apextradez.com owner Alerts for every type of trader

122Followers

110Following

549Visitors